Intensified Biomanufacturing
Learn how Syngene is achieving three to four-fold higher titers of mAbs using its Intensified Fed-Batch process
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
Publication: mAbs
Minimizing environmental footprint the Syngene way
How Syngene is driving behavioural change in responsible use of natural resources while researching new technology and opportunities to improve its sustainability performance continuously.
Enabling early assessment of drug targets to maximize clinical and commercial success
Comprehensive diligence around a target at the start of a discovery program can make the difference between success and failure. Learn how Syngene’s Target Assessment service enables informed decision-making resulting in increased clinical and commercial success.
Integrated or Standalone: How the industry thinks about drug development outsourcing
Read this white paper to gain insights about perceptions around integrated and standalone outsourcing. The white paper is based on surveys conducted across emerging biopharma, mid-size and large pharma in North America, Europe and other regions.
Essential In vivo Safety – Tox studies to move your molecule from Target to IND successfully
Learn about Syngene’s expertise in Safety/Tox studies that allows us to guide you through the various requirements leading to successful IND submission.
DMPK strategies to avoid drug development mistakes early
Learn the DMPK strategies that have helped Syngene scientists avoid drug development mistakes early while driving cost-effective, reproducible, high-quality data for clients.
How Syngene developed a multi-drug combination, antiparasitic drug for dogs for a leading Animal Health company
Learn how Syngene developed an antiparasitic tablet for dogs containing multiple APIs (one of which is a very low dose) in just six months.
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)
Publication: Journal of Medicinal Chemistry
Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series
Publication: Journal of Medicinal Chemistry